Revive Therapeutics Ltd - ESG Rating & Company Profile powered by AI
The page displays a free Environmental, Social and Governance analysis for Revive Therapeutics Ltd. Comprehensive Sustainability analysis of Revive Therapeutics Ltd are accessed by signing in. The SDG rating for Revive Therapeutics Ltd indicates the company's transparency towards the UN Sustainable Development Goals.
Revive Therapeutics Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.2; made up of an environmental score of 0.0, social score of 1.6 and governance score of 2.0.
1.2
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1755 | TRACON Pharmaceuticals Inc | 1.3 | Low |
| 1755 | Trimurthi Ltd | 1.3 | Low |
| 1779 | Revive Therapeutics Ltd | 1.2 | Low |
| 1779 | Cell Biotech Co Ltd | 1.2 | Low |
| 1779 | Aurisco Pharmaceutical Co Ltd | 1.2 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Revive Therapeutics Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Revive Therapeutics Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Revive Therapeutics Ltd report the average age of the workforce?
Sign up for free to unlockDoes Revive Therapeutics Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Revive Therapeutics Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Revive Therapeutics Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Revive Therapeutics Ltd offer flexible work?
Sign up for free to unlockDoes Revive Therapeutics Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Revive Therapeutics Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Revive Therapeutics Ltd conduct supply chain audits?
Sign up for free to unlockDoes Revive Therapeutics Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Revive Therapeutics Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Revive Therapeutics Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Revive Therapeutics Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Revive Therapeutics Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Revive Therapeutics Ltd disclose water use targets?
Sign up for free to unlockDoes Revive Therapeutics Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Revive Therapeutics Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Revive Therapeutics Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Revive Therapeutics Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Revive Therapeutics Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Revive Therapeutics Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Revive Therapeutics Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Revive Therapeutics Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Revive Therapeutics Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Revive Therapeutics Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Revive Therapeutics Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Revive Therapeutics Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Revive Therapeutics Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Revive Therapeutics Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Revive Therapeutics Ltd disclose its waste policy?
Sign up for free to unlockDoes Revive Therapeutics Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Revive Therapeutics Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Revive Therapeutics Ltd disclose energy use targets?
Sign up for free to unlockDoes Revive Therapeutics Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Revive Therapeutics Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Revive Therapeutics Ltd
These potential risks are based on the size, segment and geographies of the company.
Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company offers cannabinoid pharmaceutical portfolio that focuses on rare inflammatory diseases. It is developing Bucillamine, which is in Phase 3 clinical study for the treatment of infectious diseases, including influenza and COVID-19; Psilocybin that is in Phase 1 clinical study for treating methamphetamine use disorder; Psilocin for the treatment of depression, anxiety, bi-polar disorder, bulimia and anorexia nervosa, and other diseases; and cannabidiol for treating autoimmune hepatitis and ischemia and reperfusion injury from organ transplantation. Revive Therapeutics Ltd. has research collaboration agreements with PharmaTher Inc. for the development of psilocybin in the treatment of cancer and the discovery of other uses of undisclosed psychedelic compounds; North Carolina State University for the development of a biosynthetic version of psilocybin based on a natural biosynthesis enzymatic platform; the University of California, San Francisco to explore the use of Bucillamine as a treatment for severe COVID-19; University of Health Sciences Antigua for the clinical research of psychedelics; and PharmaTher for the development of psilocybin microneedle patch. The company was incorporated in 2012 and is headquartered in Toronto, Canada.